Soaring Demand Set to Propel Respiratory Inhaler Devices Market to $59.11 Billion by 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Respiratory Inhaler Devices Market Through 2025?
The market size for respiratory inhaler devices has seen robust growth in the past years. The market is projected to expand from a value of $41.35 billion in 2024 to an estimated value of $43.98 billion in 2025, with a compound annual growth rate (CAGR) of 6.4%. This historic growth rate is linked to factors including the prevalence of smoking, allergic disorders, innovations in pharmaceuticals, and an aging population.

What's the Projected Size of the Global Respiratory Inhaler Devices Market by 2029?
In the foroming years, the market size for respiratory inhaler devices is predicted to experience substantial growth, expanding to $59.11 billion in 2029, with a compound annual growth rate (CAGR) of 7.7%. The growth during the projected period is attributed to factors such as concerns over air quality, integration of digital health, emphasis by regulators on inhaler safety, and personalized treatments. The forecast period will witness trends like miniaturization of inhaler devices, the introduction of sustainable and eco-friendly inhalers, increased focus on home-based care, and technological advancements.

View the full report here:
https://www.thebusinessresearchcompany.com/report/respiratory-inhaler-devices-global-market-report

Top Growth Drivers in the Respiratory Inhaler Devices Industry: What's Accelerating the Market?
The escalation of respiratory ailments is anticipated to fuel the expansion of the respiratory inhaler devices market in the future. These conditions tend to impact the lungs and overall respiratory system, resulting in breathing issues and compromised lung function. Respiratory inhaler apparatuses are deployed to administer medicine directly into the lungs, offering quick and focused alleviation for respiratory disorders such as asthma, chronic obstructive pulmonary disease (COPD), respiratory syncytial virus infection and other respiratory issues. For example, data from the Centers for Disease Control and Prevention - a national public health entity in the United States - indicates that in March 2023, there was an increase in tuberculosis (TB) cases in the United States, going up to 8,300 in 2022 from 7,874 cases in 2021. Hence, the escalating incidence of respiratory diseases drives the growth of the respiratory inhaler devices market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13014&type=smp

What Are the Key Trends Driving Respiratory Inhaler Devices Market Growth?
Leading companies in the respiratory inhaler devices market are embracing innovative technologies, such as metered dosage inhalers, to maintain their market standing. A metered dosage inhaler (MDI) is a portable aerosol instrument that provides an exact dose of medication to the lungs through a mist or inhaled spray. For example, in February 2022, AptarGroup Inc., a company in the US that manufactures consumer dispensing packaging and drug delivery devices, introduced HeroTracker Sense. This advanced digital solution for respiratory health transforms a traditional metered dosage inhaler (pMDI) into an intelligent, interconnected medical device. HeroTracker Sense is designed to monitor the utilization of MDIs by patients and ensure improved compliance with their prescribed therapy, enhancing the quality of life for patients worldwide suffering from chronic respiratory diseases like asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and other respiratory issues induced by COVID-19. HeroTracker Sense offers valuable analytical data and insights into patient training, initiation, and performance to healare providers (HCPs) via the Aptar Pharma Cohero Health BreatheSmart Connect portal.

What Are the Main Segments in the Respiratory Inhaler Devices Market?
The respiratory inhaler devices market covered in this report is segmented -

1) By Product: Dry Powder Inhalers, Metered Dose Inhalers, Nebulizers
2) By Technology: Manually Operated Inhaler Devices, Digitally Operated Inhaler Devices
3) By Disease Indication: Asthma, Chronic Obstructive Pulmonary Disease, Pulmonary Arterial Hypertension, Other Indications
4) By End User: Hospitals And Clinics, Respiratory Care Centers, Other End Users

Subsegments:
1) By Dry Powder Inhalers: Single-Dose Inhalers, Multi-Dose Inhalers
2) By Metered Dose Inhalers: CFC-Based MDIs, HFA-Based MDIs
3) By Nebulizers: Jet Nebulizers, Ultrasonic Nebulizers, Mesh Nebulizers

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13014&type=smp

Which Top Companies are Driving Growth in the Respiratory Inhaler Devices Market?
Major companies operating in the respiratory inhaler devices market are Merck & Co. Inc., Novartis AG, AstraZeneca PLC, Gerresheimer AG, GlaxoSmithKline PLC, 3M, Boehringer Ingelheim International GmbH, Koninklijke Philips N.V., Viatris Inc., Teva Pharmaceutical Industries Ltd., Catalent Inc., Perrigo Company PLC, AptarGroup Inc., Recipharm AB, Chiesi Farmaceutici S.p.A., Cipla Limited, Hikma Pharmaceuticals PLC, Zydus Lifesciences Limited, Lupin Limited, Glenmark Pharmaceuticals Ltd., Orion Corporation, Sumitomo Pharma America Inc., Beximco Pharmaceuticals Ltd., Hovione Limited, Vectura Group Limited, H&T Presspart Manufacturing Ltd., Pari Medical Holding GmbH, OMRON Healare Europe B.V., Medisol Lifescience Pvt. Ltd., Consort Medical plc.

Which Regions Will Dominate the Respiratory Inhaler Devices Market Through 2029?
North America was the largest region in the respiratory inhaler devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in respiratory inhaler devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13014

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email:saumyas@tbrc.info
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.